300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Film
Oil and Gas
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Real Estate
Sporting Goods
Music
Art
Medical
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Mobile Advertising
Web3
Android
Recruiting
Impact
Proptech
Hardware
Transportation
Biotech
Enterprise
Sustainability
Community
Media (Entertainment)
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Burkina Faso
Africa
LATAM
Oman
Puerto Rico
Poland
Guernsey
China
Cameroon
Colombia
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Seychelles
Moldova
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical VC Funds & Investors in Italy (November 2026)

The most active venture capital funds investing in Italy Medical startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Italy Medical startup companies. Find investors to raise a Seed, Series A or Venture - Series Unknown round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
CDP Venture Capital
VC Fund
16 Italy, United States, Switzerland Seed, Series A, Venture - Series Unknown Software, Artificial Intelligence, Health Care $483k–$23M
Italian Angels for Growth
VC Fund
8 Italy, United States, United Kingdom Seed, Angel, Series A Software, E-Commerce, Health Care $242k–$14M
Innogest Capital
VC Fund
6 Italy, United States, Spain Series A, Venture - Series Unknown, Series B Health Care, Medical, Medical Device $1.1M–$32M
Panakes Partners
VC Fund
6 Italy, Switzerland, United Kingdom Series B, Series A, Series C Health Care, Medical, Biotechnology $4.5M–$110M
LIFTT
VC Fund
5 Italy, United Kingdom, France Seed, Series A, Venture - Series Unknown Biotechnology, Software, Health Care $338k–$118M
CDP Equity
VC Fund
4 Italy, United States, United Kingdom Seed, Series A, Pre-Seed Information Technology, Software, Health Care $177k–$13M
Vertis
VC Fund
4 Italy, United States, United Kingdom Seed, Series A, Venture - Series Unknown Software, Health Care, Biotechnology $964k–$25M
Invitalia Ventures
VC Fund
4 Italy, United States, United Kingdom Series A, Seed Software, Medical, B2B $292–$6.2M
Indaco Venture Partners
VC Fund
4 Italy, United Kingdom, Switzerland Series A, Series B, Venture - Series Unknown Biotechnology, Health Care, Medical $2.3M–$89M
XGEN Venture
VC Fund
3 Italy, Sweden, Germany Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $4.6M–$141M
Lazio Innova
VC Fund
3 Italy, United Kingdom Seed, Pre-Seed, Grant Health Care, Software, Biotechnology $22k–$1.9M
Scientifica Venture Capital
VC Fund
3 Italy, Sweden, Finland Seed, Pre-Seed Biotechnology, Health Care, Manufacturing $209k–$2.9M
Angelini Ventures
VC Fund
3 United States, Italy, France Series A, Seed, Series B Health Care, Biotechnology, Medical $3.3M–$132M
INGENIUM Emilia Romagna
VC Fund
3 Italy Seed, Series A, Angel Medical, Health Care, Biotechnology $264k–$2.8M
Neva SGR
VC Fund
2 Italy, United States, Israel Series B, Series A, Series C Software, FinTech, Information Technology $6M–$141M
Fin Posillipo Spa
VC Fund
2 Italy, United Kingdom Seed, Pre-Seed, Venture - Series Unknown Sales, Medical, Internet $140k–$162k
Lumen Ventures
VC Fund
2 Italy, United States Seed, Series A, Pre-Seed Health Care, Medical, Software $1.4M–$14M
La Finanziaria Trentina
VC Fund
2 Italy Venture - Series Unknown, Private Equity Health Care, Manufacturing, Retail $972k–$4.6M
European Investment Bank
VC Fund
2 France, Germany, Spain Debt Financing, Post-IPO Debt, Venture - Series Unknown Energy, Biotechnology, Health Care $8.7M–$587M
Club degli Investitori
VC Fund
2 Italy, Switzerland, United Kingdom Seed, Series A, Pre-Seed Software, Health Care, E-Commerce $197k–$30M
ENEA Tech e Biomedical
VC Fund
2 Italy, Finland Venture - Series Unknown, Series A, Grant Health Care, Biotechnology, Medical Device $530k–$21M
3B Future Health Fund
VC Fund
2 United States, Italy, United Kingdom Series B, Series A, Seed Biotechnology, Therapeutics, Medical $1.5M–$75M
Principia SGR
VC Fund
2 Italy, United States, United Kingdom Venture - Series Unknown, Series A Health Care, Biotechnology, Software $1M–$9.9M
Antin Infrastructure Partners
VC Fund
2 United States, Italy, United Kingdom Private Equity, Seed Energy, Renewable Energy, Commercial $108M–$1B
Alchimia Investments
VC Fund
2 Italy, United Kingdom, Israel Series A, Seed, Venture - Series Unknown Software, Health Care, Medical $2.3M–$40M
The Techshop
VC Fund
2 Italy, Portugal, Switzerland Seed, Pre-Seed, Series A Artificial Intelligence, Software, FinTech $322k–$120M
Opes Italia
VC Fund
2 Italy, Spain Venture - Series Unknown, Series A, Seed E-Commerce, Leisure, Medical $440k–$7.5M
P101
VC Fund
2 Italy, Spain, United States Seed, Series A, Venture - Series Unknown Software, E-Commerce, Information Technology $327k–$15M
Sefea Impact
VC Fund
2 Italy Venture - Series Unknown, Seed, Series A Medical, Health Care, Information Services $777k–$5.9M
Fountain Healthcare Partners
VC Fund
2 Ireland, United States, France Series A, Series B, Series C Health Care, Biotechnology, Medical $4.1M–$110M
Evotec
VC Fund
2 United States, Germany, United Kingdom Series A, Seed, Series B Biotechnology, Health Care, Therapeutics $8.5M–$139M
Equiter
VC Fund
2 Italy Seed, Series B Medical, Health Care, Information Technology $2.2M–$4M
Fondazione Social Venture Giordano dell'Amore
VC Fund
2 Italy, Mexico Venture - Series Unknown, Seed, Pre-Seed Health Care, Software, Information Technology $29k–$841k
Andera Partners
VC Fund
1 France, United States, Germany Series B, Private Equity, Series A Biotechnology, Health Care, Medical $10M–$237M
Si14
VC Fund
1 Italy, United States Seed Medical, mHealth, Diabetes $250k–$1.6M
RedSeed Ventures
VC Fund
1 Italy, Israel, United States Seed, Series A, Series B Software, Information Technology, Analytics $669k–$16M
a|impact
VC Fund
1 Italy Seed, Venture - Series Unknown, Series A Health Care, Fashion, Wellness $380k–$3.3M
Metaventures
VC Fund
1 Italy, Brazil, United Kingdom Venture - Series Unknown Gaming, Medical, PC Games $174k–$8M
GM&C Life Sciences Fund
VC Fund
1 United Kingdom, Italy, Germany Seed, Venture - Series Unknown, Series A Health Care, Biotechnology, Medical $94k–$5.8M
GCM Group
VC Fund
1 Italy Seed Medical, Genetics, Health Care
Finalca
VC Fund
1 Italy Seed Medical, Genetics, Health Care
Index Ventures
VC Fund
1 United States, United Kingdom, France Series A, Series B, Seed Software, E-Commerce, Internet $1.3M–$100M
MPM Capital
VC Fund
1 United States, Canada, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $9M–$125M
Rancilio Cube
VC Fund
1 United States, Italy, Germany Seed, Series A, Series B E-Commerce, Software, Financial Services
UniCredit
VC Fund
1 Italy, Germany, United States Debt Financing, Post-IPO Debt, Pre-Seed Renewable Energy, Energy, Manufacturing $197k–$2.1B
European Commission
VC Fund
1 France, Spain, United Kingdom Grant, Seed, Pre-Seed Software, Health Care, Biotechnology $55k–$36M
ArchiMed
VC Fund
1 Italy, France, Japan Private Equity, Venture - Series Unknown Health Care, Biotechnology, Pharmaceutical
50 Partners Health
VC Fund
1
Claris Ventures
VC Fund
1 Italy, United Kingdom Seed, Series A, Series B Biotechnology, Health Care, Life Science $2.1M–$23M
Seroba Life Sciences
VC Fund
1 Ireland, United States, United Kingdom Series A, Series B Health Care, Biotechnology, Medical $4.6M–$105M
Access all 192 VC funds in Italy Medical startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

CDP Venture Capital
VC Fund · Rome, Lazio, Italy · 16 investments in Italy Medical startups

CDP Venture Capital Sgr - National Innovation Fund aims to make venture capital a cornerstone of the country's economic development and innovation, creating the conditions for an overall and sustainable growth of the venture capital ecosystem.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Italy, United States, Switzerland

Investor stats

  • Total investments: 305
  • Round size: Seed $483k–$8.1M; Series A $3.3M–$23M; Venture - Series Unknown $652k–$21M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: May invest from a new fund soon — raised $212M in 2021

Portfolio highlights

  • Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
  • Phononic Vibes — The Art of Noise Management START NOW The Art of Noise Management START NOW Phononic Vibes Technology Working with the MetaMaterial technology, Phononic Vibes
  • Tretau — E-mobility is powered by its core - the electric motor. We at Tau are at the very core of the core: the copper winding wire, the magnetic core, the electrical steel.We just make it bet.
Show all investments...

Italian Angels for Growth
VC Fund · Milan, Lombardia, Italy · 8 investments in Italy Medical startups

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunity at IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Health Care
  • Stage:Seed, Angel, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 106
  • Round size: Seed $331k–$5.1M; Angel $242k–$987k; Series A $3M–$14M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Cato AI — Search, analyze and bid on Italian public tenders with AI, automating the manual work for bid offices and sales teams.
  • AUDIOGEN — Generate your sounds with AI. Create an infinite world of sounds - sound effects, samples, and music, instantly. Get Started Free.
  • Alomana — Alomana is an organization that focuses on harnessing the power of artificial intelligence and data analytics to drive insights and innovation across various industries. They offer a range of services, including data analysis, machine learning model development, and AI-driven solutions tailored to meet the specific needs of their clients. Datasparkemphasizes the importance of data-driven decision-making and works closely with businesses to implement strategies that enhance operational efficiency and improve outcomes. With a commitment to advancing the use of AI and data analytics, Dataspark aims to empower organizations to unlock the full potential of their data and stay competitive in a rapidly changing market.
Show all investments...

Innogest Capital
VC Fund · Milan, Lombardia, Italy · 6 investments in Italy Medical startups

We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Italy, United States, Spain

Investor stats

  • Total investments: 68
  • Round size: Series A $1.1M–$11M; Series B $2.7M–$32M; Venture - Series Unknown $1.7M–$12M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: May invest from a new fund soon — raised $95M in 2015

Portfolio highlights

  • Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. ​ Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
  • Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
  • BetaGlue Technologies — BetaGlue Technologies engage in the research and offers anticancer products.
Show all investments...

Panakes Partners
VC Fund · Milano, Lombardia, Italy · 6 investments in Italy Medical startups

Panakès Partners is a Venture Capital firm, based in Milan, which invests in the most ambitious companies and teams, developing revolutionary technologies and products, in the field of life sciences, aiming to improve the lives of people around the world. Panakès, founded in 2015 by Fabrizio Landi, Alessio Beverina and Diana Saraceni, has 250 million under management.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: Italy, Switzerland, United Kingdom

Investor stats

  • Total investments: 43
  • Round size: Series A $4.5M–$79M; Series B $10M–$60M; Series C $18M–$110M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: Likely still investing — raised $187M in 2023

Portfolio highlights

  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
  • Endovascular Engineering — Endovascular Engineering is a medical technology company focused on developing and deploying advanced clot removal solutions for the treatment of venous thromboembolism. It specializes in thrombectomy technologies designed to improve clinical outcomes and procedural efficiency in minimally invasive vascular interventions. The company’s flagshipinnovation is the Hēlo™ Thrombectomy System, a catheter-based device that uses a combination of mechanical agitation and physician-controlled aspiration to remove blood clots. Its technology emphasizes features such as a self-expanding funnel design and dual-action functionality to enhance clot engagement and navigation through complex anatomies. Endovascular Engineering primarily serves healthcare providers, including interventional cardiologists and radiologists, supporting the treatment of conditions such as pulmonary embolism and deep vein thrombosis.
Show all investments...

LIFTT
VC Fund · Turin, Piemonte, Italy · 5 investments in Italy Medical startups

A not-only-profit operating investment company, eager to create a bridge between innovative ideas, territory and capital.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Italy, United Kingdom, France

Investor stats

  • Total investments: 75
  • Round size: Seed $338k–$4.7M; Series A $2.8M–$21M; Venture - Series Unknown $495k–$118M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • CareGlance — CareGlance is the provider of real-time monitoring systems based on SS-OCT technology. Fast, precise and developed for the industry!
  • Rainbow Crops — Rainbow Crops is a next-generation Agtech company developing climate-resilient, high-performing crop varieties.
  • Wearable Robotics — Wearable Robotics produces and develops wearable robotic systems and exoskeletons for rehabilitation, assistance and human-power augmentation.
Show all investments...

CDP Equity
VC Fund · Milan, Lombardia, Italy · 4 investments in Italy Medical startups

CDP Equity is a holding company that has been set up to boost the Italian economy by investing venture capital in companies of "significant national interest" (as envisaged by the decrees of the Ministry of Economy and Finance of 3 May 2011 and 2 July 2014) or in companies with "economic, financial and capital balance, with adequateprospects of profitability and development, capable of generating value for investors"

Show more...

Investment focus

  • Industry: Information Technology, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 41
  • Round size: Seed $177k–$3.6M; Pre-Seed $230k–$3.6M; Series A $2.3M–$13M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Gility — Gility is a digital learning platform that collaborates with business schools and training institutions for an effective training offer. Established in 2022, it was supported by CDP Venture Capital and BPER Banca.
  • Soplaya — Soplaya is a B2B food company connecting chefs and farmers to build a diverse, sustainable, and efficient food system.By providing data and transparency to an opaque supply chain, we help chefs to simplify purchases, get a wider selection of products and save money and farmers to increase their margins and get easy access to the market.We lovequality food as much as technology and automation. We are rebels: we love transparency and how the internet is capable of bringing the long tail to the market. We're excited about the fact that the restaurant supply chain hasn't basically changed since 40 years, and was technology reluctant for a long time, but restaurants necessities changed dramatically in the last 3 years.We’re becoming the standard layer for restaurant purchasing across Europe, by bringing transparency and simplicity in the procurement phase, increasing order frequency, promoting lean inventory and food waste reduction.
  • Valvitalia SpA. — VALVITALIA is a leading group in the field of design, production, and overall supply of equipment and components intended for the petroleum, water, natural gas industries, and petrochemical industry as well as electrical power stations. The group works mainly with valves (core product), actuators, pipe fittings, flanges and systems for measuring,filtering, and regulating fluids and gases and with FireFighting systems. VALVITALIA was set up with the precise objective of becoming the leading Italian group able to offer such a wide range of products and to compete with the large American multinationals that have always dominated this field. This young company has extensive experience in the sector, thanks to its professional management and historical brands in the valve world that have been taken on by the Group, including: ROTOR, DELTA V.E., THEVIGNOT, VANADOUR, VITAS, TORMENE T.G.T. and TECNOFORGE. VALVITALIA has always included safety and respect for the environment and its employees among its priorities.
Show all investments...

Vertis
VC Fund · Milan, Lombardia, Italy · 4 investments in Italy Medical startups, 9 in the past 12 months

Capitali e competenze per accelerare l'innovazione. Attraverso fondi di investimento chiusi investiamo in startup, scaleup e PMI innovative

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 76
  • Round size: Seed $964k–$4M; Series A $1.5M–$11M; Venture - Series Unknown $1.1M–$25M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: May invest from a new fund soon — raised $49M in 2021

Portfolio highlights

  • Clastix — Clastix is an enterprise Kubernetes infrastructure company, purpose-built to solve the operational challenges that emerge when Kubernetes runs at scale: cluster sprawl, fragile multi-tenancy, and the mounting cost of over-provisioned hardware and memory. The company's breakthrough is architectural. By combining hosted control planes with hard multi-tenancy, Clastix enables telcos, cloud providers, MSPs, and platform teams to run many isolated Kubernetes environments more efficiently, securely, and cost-effectively than traditional approaches allow. Clastix was founded by engineers who understood these pain points from direct experience running Kubernetes in production. That same commitment to quality engineering runs through everything the company builds – an approach shaped as much by Italian engineering tradition as by technical rigour. The result is infrastructure software that is functional, elegant, and highly scalable. The company's open source credentials are equally strong. Clastix donated Capsule to the Cloud Native Computing Foundation, co-founded Cloud Native Days Italy, and continues to evolve Kamaji – contributing not just code, but community and standards to the broader Kubernetes ecosystem. Clastix's platform is trusted by customers including NVIDIA and Mistral AI – organisations that operate some of the most demanding and innovation-intensive infrastructure environments in the world. Their confidence is a direct measure of what the platform can handle. Headquartered in Naples, Italy, with customers and partners across cloud, data centre, edge, and AI infrastructure globally, Clastix is where world-class engineering meets the real operational complexity of modern Kubernetes at scale.
  • Tiledesk — Boost customer engagement with Tiledesk. Discover our conversational automation ready to use. Personalized experiences, improved conversion and retention.
  • Comestai — Comestai focuses on digital and in-person treatment pathways for people with eating disorders. The company operates a hybrid care model that combines online consultations with psychologists, psychotherapists, psychiatrists, and clinical dietitians and access to physical clinical spaces. It offers virtual multidisciplinary therapy programs tailoredto individuals and families, with structured assessments and follow-up sessions. Comestai also develops corporate welfare programs that provide counseling groups, psychoeducational tools, and consultation modules for employees in partner organizations. Through its La Palestra di Animenta branch, it delivers structured professional training, including multi-module courses and continuing medical education pathways for clinicians treating eating disorders. Comestai additionally produces digital educational content such as the Hilde newsletter to support families and caregivers with practical information and clinical guidance about eating disorders.
Show all investments...

Invitalia Ventures
VC Fund · Rome, Lazio, Italy · 4 investments in Italy Medical startups

Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation. Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it

Show more...

Investment focus

  • Industry: Software, Medical, B2B
  • Stage:Series A, Seed
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 30
  • Round size: Seed $292–$1.6M; Series A $900k–$6.2M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — raised $103M in 2017

Portfolio highlights

  • Ecomate — The ESG Rating platform for every company
  • BigProfiles — BigProfiles is an Artificial Intelligence Platform designed for Utilities, Telcos, Banks, Insurance companies and Retails.Large companies such as Teleperformance, Eni, Unicef already have already successfully subscribed to our services.BigProfiles is the No-Code Artificial Intelligence Platform for sales and antichurn that predicts thelikelihood to purchase and churn of each customer in a CRM, before proceeding to contact him in a sales or retention campaign.
  • Codemotion — Meetups, hackathons, training tours and conferences for developers and tech leaders.
Show all investments...

Indaco Venture Partners
VC Fund · Milan, Lombardia, Italy · 4 investments in Italy Medical startups

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: Italy, United Kingdom, Switzerland

Investor stats

  • Total investments: 50
  • Round size: Series A $3.5M–$33M; Series B $8.9M–$89M; Venture - Series Unknown $2.3M–$21M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — raised $302M in 2018

Portfolio highlights

  • Newcleo — newcleo is the clean and safe nuclear technology company. Privately funded and headquartered in London, UK, newcleo was launched in 2021 to be a disruptor in the field of nuclear energy. Its mission is to generate safe, clean and inexhaustible energy for the world, through a radically innovative combination of existing, accessible technologies.newcleo is building the next generation system with the goals to: (1) eliminate the need for geological repositories by using a fast neutron flux avoiding production of long life radioactive elements; (2) develop an Accelerator Driven System (ADS), based on the intrinsically safe coupling of a particle accelerator and a sub-critical reactor; (3) accelerate the development of new fuel cycles, including thorium, that provide economic, clean, safe and inexhaustible energy from nuclei and the opportunity to burn the long-lived nuclear waste produced by the old generation of nuclear reactors.With visionary co-founders, newcleo brings together a team of engineers with deep knowledge of nuclear energy with younger recruits with a fresh mindset, working to design an innovative micro Lead Fast Reactor with significant commercial applications, for example in shipping. newcleo wants to be the first step toward the evolution of its industry to become fully respectful of people and the environment. To develop a new, sustainable, and completely safe way of generating nuclear energy that will lead humanity to zero emissions, and to the mitigation of global warming.
  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Show all investments...

XGEN Venture
VC Fund · Milan, Lombardia, Italy · 3 investments in Italy Medical startups

XGEN Venture is an Italian alternative investment fund manager (Società di Gestione del Risparmio, or SGR) with over 15 years of experience in the startup process and the development of innovative solutions for high unmet medical needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: Italy, Sweden, Germany

Investor stats

  • Total investments: 12
  • Round size: Series A $11M–$98M; Series B $4.6M–$141M
  • Lead/follow: 50% lead, 50% follow
  • Last fund: Likely actively investing — fresh fund, raised $186M in 2024

Portfolio highlights

  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • Dialybrid — Dialybrid provide product that include silkothane arteriovenous graft, SAG biomimetic nanostructure, and situ tissue engineering products. Their proprietary innovative technology, silkothane, is a hybrid material combining silk fibroin and polyurethane. Their aim is to develop a novel semi-degradable vascular access for hemodialysis.
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Lazio Innova
VC Fund · Rome, Lazio, Italy · 3 investments in Italy Medical startups

Lazio Innova is a venture capital firm with its headquarters in Rome in Italy. The firm provides services in areas such as credit support and guarantees, interventions in risk capital, internationalization services, promotion of business networks and services for the creation and enterprise development.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Pre-Seed, Grant
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 35
  • Round size: Seed $400k–$1.9M; Grant $22k–$343k; Pre-Seed $58k–$518k
  • Lead/follow: 43% lead, 57% follow
  • Last fund: May invest from a new fund soon — raised $27M in 2018

Portfolio highlights

  • HEU — HEU is a legaltech company that automates and manages legal documents and allows users to edit and share them.
  • Tech4All — We support the study by using AI.
  • GeneSys Bio — Antimicrobial Resistance (AMR) is a global health emergency projected to cause 10 million deaths annually by 2050. The crisis is fueled by slow, conventional diagnostics that take 3-5 days, forcing the empirical use of broad-spectrum antibiotics and accelerating the spread of superbugs.GeneSys Bio is commercialising a breakthrough solution: afully automated, sample-to-result molecular diagnostic platform that identifies infectious pathogens and their critical antibiotic resistance genes in under 30 minutes with >99% sensitivity and specificity. Our portable, laptop-sized device combines proprietary nucleic acid amplification with an AI-driven engine to deliver clear, actionable results directly to clinicians, veterinarians, and public health officials.Our platform is a modular "One Health" solution, adaptable via disease-specific kits for human, veterinary, and environmental applications. We are entering the market with a diagnostic for Urinary Tract Infections (UTIs), a condition affecting over 500 million people annually and a primary driver of antibiotic misuse. By enabling targeted therapy at the first patient encounter, our platform is set to reduce treatment costs by up to 13%, cut follow-up visits, and decrease mortality from complicated infections by 50%.GeneSys Bio is positioned to capture a significant share of this market by bridging the critical gap between speed, laboratory-grade accuracy, and accessibility. We are not just creating a device; we are building the future of decentralized infectious disease diagnostics to safeguard global health for generations to come
Show all investments...

Scientifica Venture Capital
VC Fund · Roma, Lazio, Italy · 3 investments in Italy Medical startups

Scientifica Venture Capital offers private equity and venture capital investment services for Italy based startups and firms.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Seed, Pre-Seed
  • Geography: Italy, Sweden, Finland

Investor stats

  • Total investments: 17
  • Round size: Seed $209k–$2.9M; Pre-Seed $209k–$541k
  • Lead/follow: 76% lead, 24% follow
  • Last fund: Likely actively investing — fresh fund, raised $209M in 2024

Portfolio highlights

  • Relicta — Relicta solution is a water-soluble bioplastic material obtained from fish processing waste and suitable for packaging solutions.
  • OhmSpace — OhmSpace provides the satellite market with reliable resistojets.
  • LOTO Biotech — LOTO Biotech is a biotechnology platform focused on supporting the development of treatments for rare diseases, particularly those caused by dominant negative genetic mutations.
Show all investments...

Angelini Ventures
VC Fund · Rome, Lazio, Italy · 3 investments in Italy Medical startups, 13 in the past 12 months

Angelini Ventures is an investment firm.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: United States, Italy, France

Investor stats

  • Total investments: 38
  • Round size: Seed $3.3M–$45M; Series A $11M–$105M; Series B $19M–$132M
  • Lead/follow: 37% lead, 63% follow

Portfolio highlights

  • MMI — The future of Microsurgery: microinstruments that expand the possibilities of surgical interventions. Wristed robotic microinstruments for unprecedented results in microsurgery.
  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • RougeTx — RougeTx is a Netherlands-based biotech developing first-in-class small-molecule therapies for vascular diseases caused by pericyte dysfunction. Its lead candidate, RTX-001, targets hereditary haemorrhagic telangiectasia (HHT), an inherited disorder involving fragile blood vessels and recurrent bleeding.
Show all investments...

INGENIUM Emilia Romagna
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 3 investments in Italy Medical startups

INGENIUM Emilia Romagna was started with EUR 5.30 million by the Emilia Romagna region and EUR 1.7 million from fund managers. Managed by META Investment, the nine-year fund operated through the temporary acquisition of minority stakes in high-opportunity technological companies. It is now fully invested.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed, Series A, Angel
  • Geography: Italy

Investor stats

  • Total investments: 12
  • Round size: Seed $264k–$2.8M; Series A $1.1M–$2.2M
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • Fazland — Fazland is an innovative web and mobile platform developed by the Italian startup Midnight Call Srl. The platform enables private clients to compare offers for home services and it helps efficient tradesmen to get in touch with potential customers in an easy and smart way. Midnight Call Srl was founded in October 2011 in Reggio Emilia (Italy).Following an initial phase of R&D, the product has become commercially available in March 2013.Following a very encouraging first year of operations, the company recieved a seed investment from the Italian venture capital fund RedSeed Ventures and some Angel Investors in July 2014. Through continuous product improvements and a solid commercial approach, the company has managed to build a solid position in the Italian market and launch pilot tests in few European cities.
  • Passpack — Users can make and store passwords in a single, organized list, then access them from anywhere leaving no traces behind on the computer. Secure collaboration features allow users to make, send, share or provision passwords to colleagues, clients and partners -- a secure alternative to spreadsheets in the workplace. Managed via a central onlinerepository.Passpack is a free, professional tool. Optional premium upgrades are available for the micro-small business sector.
  • GreenBone Ortho — GreenBone Ortho was founded in Faenzato offer advanced and innovative solutions in the field of orthopaedics and bone regeneration, using the Rattan wood.
Show all investments...

Neva SGR
VC Fund · Turin, Piemonte, Italy · 2 investments in Italy Medical startups

Neva SGR, part of the Intesa Sanpaolo Group and wholly owned by the Intesa Sanpaolo Innovation Center, plans and manages investment funds for professional investors interested in seizing diversification and high-yield opportunities offered by Venture Capital investments. Neva SGR can count on Intesa Sanpaolo Innovation Center’s and Intesa Sanpaolo Group’s strength, financial resources, know-how and network of relationships, a unique source of value on the market. Neva SGR is the perfect blend of strength, reputation and stability of the Intesa Sanpaolo Group and the best practices of international venture capital firms. Neva SGR aims to boost the Italian economy through new technologies and to be market maker of the VC asset class of venture capital in Italy.

Show more...

Investment focus

  • Industry: Software, FinTech, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: Italy, United States, Israel

Investor stats

  • Total investments: 53
  • Round size: Series A $6M–$64M; Series B $17M–$141M; Series C $28M–$110M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • iwoca — Iwoca provides financing to businesses for various purposes, including bridging short-term cashflow gaps and investing in stock opportunities. It services retailers, restaurants, hotels, and other businesses. It offers flexible repayment options from 1 day to 24 months, with no penalties for early repayment. Iwoca helps businesses manage cash flowgaps and invest in growth opportunities, enhancing their financial capabilities.
  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • Straiker — Security for agentic AI applications built from the ground up with fine-tuned models to protect and secure every layer of your agentic AI stack.
Show all investments...

Fin Posillipo Spa
VC Fund · 2 investments in Italy Medical startups

Familiy Office of Petrone Group

Show more...

Investment focus

  • Industry: Sales, Medical, Internet
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 4
  • Round size: Pre-Seed $140k–$162k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Verado — Verado is a global technology platform designed to empower everyone to instantly monetize their belongings. Whether selling an old laptop or unlocking cash by collateralizing valuables for a loan, our technology is crafted to enable consumers to do so with unprecedented ease. Snap a picture of your electronics, valuables, apparel or otherbelongings, get an instant appraisal through our real time valuation engine, and receive a direct payout to your bank account immediately. We are a deep technology company, envisioning a world where products’ lifecycle is lengthened and the ecological burden of trashing minimised. What exists currently is falling short of the experience modern consumers expect. They value convenience, comfort and speed, and don’t deem existing selling channels even marginally satisfactory. They are tired of the tedious paper-work, negotiating with uncommitted buyers through outdated messaging systems, managing the logistics, and the time-consuming nature of the process. Through our innovative solutions, we are cutting down from days to seconds the time it takes to receive a valuation; and from weeks to hours, the time necessary to sell!Verado is changing the rules of the game - It’s simplicity, re-engineered. We believe selling should be as seamless as buying. Therefore, rather than accumulating unused products at home or worse letting them end up in a landfill forever - we enable individuals to monetize their unwanted things, free up valuable space in their home and reduce their need for borrowing whilst simultaneously minimizing their ecological footprint.
  • BetaGlue Technologies — BetaGlue Technologies engage in the research and offers anticancer products.
Show all investments...

Lumen Ventures
VC Fund · London, England, United Kingdom · 2 investments in Italy Medical startups

Lumen Ventures is a venture capital firm that focuses on seed investments, early-stage investments, and private equity.

Show more...

Investment focus

  • Industry: Health Care, Medical, Software
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, United States

Investor stats

  • Total investments: 11
  • Round size: Seed $1.4M–$5.3M; Series A $5.3M–$14M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $29M in 2020

Portfolio highlights

  • qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
  • Serenis Health — Serenis Health provides video-based psychotherapy, coaching, and psychological support courses. It believes that the internet is critical to increasing access to mental health care. It makes use of data and digital tools to improve the efficacy of therapies. But, unlike other platforms, it is also a medical center, which means it is responsible forcourse quality and must meet the same standards as any polyclinic.
  • AutoConnexa — Scopri AutoConnexa, l'assicurazione online per la tua auto che premia lo stile di guida. Con Drive Connexa, meglio guidi e meno paghi.
Show all investments...

La Finanziaria Trentina
VC Fund · Trento, Trentino-Alto Adige, Italy · 2 investments in Italy Medical startups

La Finanziaria Trentina is s a private equity firm. It invests in energy, infrastructure, and real estate sectors.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Retail
  • Stage:Venture - Series Unknown, Private Equity
  • Geography: Italy

Investor stats

  • Total investments: 13
  • Round size: Venture - Series Unknown $972k–$4.6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • VENPA — Noleggio Piattaforme Aeree e Noleggio Macchine Movimento Terra. Scopri tutti i mezzi da cantiere Venpa!
  • Tony Kart — Tony Kart is an automotive company specializing in designing and manufacturing chassis, OTK kart parts, and karting wears.
  • LMA srl - Aerospace Technology — LMA provides high-precision mechanical processes for aeronautics and aerospace. It operates in precision mechanics for civil and military aeronautical, helicopter, and expanding aerospace sectors.
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in Italy Medical startups

European Investment Bank operates as the lending institution of the European Union, offering loans, guarantees, and technical expertise to governments, businesses, and financial institutions. The organization focuses on areas such as climate action, digital transformation, housing development, and security-related initiatives. Its activities include funding large-scale infrastructure, supporting technology development, and facilitating access to capital for emerging and established enterprises. The bank also delivers advisory support to structure projects, improve investment readiness, and align initiatives with policy objectives.

Show more...

Investment focus

  • Industry: Energy, Biotechnology, Health Care
  • Stage:Debt Financing, Post-IPO Debt, Venture - Series Unknown
  • Geography: France, Germany, Spain

Investor stats

  • Total investments: 608
  • Round size: Post-IPO Debt $16M–$587M; Debt Financing $16M–$355M; Venture - Series Unknown $8.7M–$110M
  • Lead/follow: 82% lead, 18% follow

Portfolio highlights

  • Impress — Impress – is European leading digital orthodontic DSO of new generationWe have a defensible model with the personal touch of an in-house orthodontist, true clinical expertise, and engaging directly with consumersImpress was founded in 2019 in Barcelona with the idea of combining the best of orthodontic tradition with the most innovativetechnology in the sector. From the very beginning the vision of the Impress founders was to introduce a different business model with a strong focus on medical experience and digitalization. The company is transforming the oral healthcare industry by developing its own chain of orthodontic clinics, which are characterized by their disruptive design and modern patient experience. The founders decided to build a medical company with the personal touch of in-house orthodontists, face-to-face care, and unique clinical expertise, where the proper implementation of business processes and digitalization are at the core.In less than 2 years, Impress has managed to position itself as the European leader in the orthodontic sector, has treated more than 22.000 smiles and already has a presence in more than 80 European cities. Its innovation and quality have earned it recognition from Sifted as one of the fastest growing HealthTech companies in Europe in 2020.
  • Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
  • Dandara Solar Power SAE — Dandara Solar Power SAE is a special purpose vehicle, established to develop a major renewable energy and storage project in Upper Egypt. The entity oversees the development and operational construction of a 500 MW solar PV plant integrated with a 100 MWh Battery Energy Storage System. All electricity generated by the company is bound to be sold to the industrial manufacturer Misr Aluminum Company under a long term, take or pay power purchase agreement.
Show all investments...

Club degli Investitori
VC Fund · Torino, Piemonte, Italy · 2 investments in Italy Medical startups, 7 in the past 12 months

Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 400+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business by investing capital and by leveraging the Members' network and experience. Club degli Investitori is supported by Unicredit and KPMG Italy.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Italy, Switzerland, United Kingdom

Investor stats

  • Total investments: 118
  • Round size: Seed $197k–$8.4M; Pre-Seed $204k–$1.9M; Series A $889k–$30M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Soource — Soource is a B2B Saas product that uses AI applications to help purchasing managers to discover the best market solutions through extensive global research and automated email negotiations with thousands of suppliers worldwide.
  • Comestai — Comestai focuses on digital and in-person treatment pathways for people with eating disorders. The company operates a hybrid care model that combines online consultations with psychologists, psychotherapists, psychiatrists, and clinical dietitians and access to physical clinical spaces. It offers virtual multidisciplinary therapy programs tailoredto individuals and families, with structured assessments and follow-up sessions. Comestai also develops corporate welfare programs that provide counseling groups, psychoeducational tools, and consultation modules for employees in partner organizations. Through its La Palestra di Animenta branch, it delivers structured professional training, including multi-module courses and continuing medical education pathways for clinicians treating eating disorders. Comestai additionally produces digital educational content such as the Hilde newsletter to support families and caregivers with practical information and clinical guidance about eating disorders.
  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
ENEA Tech e Biomedical
VC Fund · Rome, Lazio, Italy · 2 investments in Italy Medical startups

ENEA Tech e Biomedical is a private foundation. It seeks to encourage the strengthening of research, development, and industrial reconversion of the biomedical sector.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Venture - Series Unknown, Series A, Grant
  • Geography: Italy, Finland

Investor stats

  • Total investments: 13
  • Round size: Series A $3.3M–$7.7M; Venture - Series Unknown $530k–$21M
  • Lead/follow: 92% lead, 8% follow

Portfolio highlights

  • CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
  • Recornea — Recornea is a developer of a corneal medical device to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.
  • Health Triage — Health Triage, crea nuove tecnologie per offrire modelli innovativi di diagnosi clinica, identificazione e cura delle malattie oncologiche.
Show all investments...

3B Future Health Fund
VC Fund · Monaco, Bayern, Germany · 2 investments in Italy Medical startups

Helsinn Investment Fund S.A. is a Luxembourg fund focused on early-stage investments in areas of high unmet patient need.

Show more...

Investment focus

  • Industry: Biotechnology, Therapeutics, Medical
  • Stage:Series B, Series A, Seed
  • Geography: United States, Italy, United Kingdom

Investor stats

  • Total investments: 40
  • Round size: Seed $1.5M–$11M; Series A $2.8M–$41M; Series B $7.4M–$75M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • GenEp — GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets. GenEp creates therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies.
  • Kainova Therapeutics — Domain Therapeutics is a biopharmaceutical company focused on GPCR in immuno-oncology. Discover more than you think on our innovative cancer treatments tackling GPCR mediated-immunosuppression
  • Navion Neurosciences — Navion Neurosciences is a preclinical-stage biotechnology company developing next-generation, precision sodium channel therapies for neurological diseases.
Show all investments...

Principia SGR
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups

Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Venture - Series Unknown, Series A
  • Geography: Italy, United States, United Kingdom

Investor stats

  • Total investments: 51
  • Round size: Series A $1.5M–$7.9M; Venture - Series Unknown $1M–$9.9M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2014

Portfolio highlights

  • KLISBio — KLISBio is a clinical-stage regenerative medicine company focused on developing innovative technology platforms based entirely on natural silk fibroin. The company, headquartered in Milan, Italy, currently has several assets under development, such as vascular graft, bone graft substitutes, rotator cuff repair, drug release, and a first-in-humanstudy on nerve repair that is ongoing at the University of Zurich, Switzerland
  • ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
  • WISE — WISE (Wiringless Implantable Stretchable Electronics) is a start-up company created in 2011 with the mission of producing the new generation of leads for neuromodulation for treatment of chronic pain and Parkinson: unbreakable, less invasive and cheaper.
Show all investments...

Antin Infrastructure Partners
VC Fund · Paris, Ile-de-France, France · 2 investments in Italy Medical startups

Antin Infrastructure Partners is a leading private equity firm focused on infrastructure investments.

Show more...

Investment focus

  • Industry: Energy, Renewable Energy, Commercial
  • Stage:Private Equity, Seed
  • Geography: United States, Italy, United Kingdom

Investor stats

  • Total investments: 16
  • Round size: Private Equity $108M–$1B
  • Lead/follow: 69% lead, 31% follow
  • Last fund: Likely still investing — raised $1.3B in 2023

Portfolio highlights

  • CityFibre — CityFibre is a brand new full fibre network built for the data age. Never worry about speed or reliability again. Connect your home and business today.
  • Power Dot — Powerdot offers electric vehicle charging solutions in convenient locations across six European countries.
  • Origis Energy — Origis Energy is powering the solar revolution with solar power and energy storage projects for utility, corporate and public sector energy clients.
Show all investments...

Alchimia Investments
VC Fund · Rome, Lazio, Italy · 2 investments in Italy Medical startups

Alchimia is an investment company primarily operating in the Venture Capital Sector. Leveraging the expertise of our team and a wide network of international advisors, we invest and co-invest in high growth potential opportunities offering capital, as well as dedicated strategic and operational resources.

Show more...

Investment focus

  • Industry: Software, Health Care, Medical
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Italy, United Kingdom, Israel

Investor stats

  • Total investments: 21
  • Round size: Seed $2.3M–$11M; Series A $4.4M–$40M; Venture - Series Unknown $5.8M–$14M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Gardin — We believe in a world in which everyone has the right to access high quality, nutritious food that is good for you and for our planet. Our environmental issues are real, something, somewhere needs to change. Gardin promises to create the step-change required by deploying its technology.
  • NoTraffic — NoTraffic has developed the first AI-powered traffic signal platform that connects road...
  • Stellar — At Stellar we bring perfect internet on the move to vehicles and passengers, leveraging the combined strength of cellular, wi-fi, and satellite networks, through AI and fully integrated solutions. We offer SaaS, data plans, and all-inclusive options for enterprise connectivity needs on the move.
Show all investments...

The Techshop
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups, 7 in the past 12 months

The Techshop is a venture capital and private equity firm that invests in B2B digital startups.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, FinTech
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Italy, Portugal, Switzerland

Investor stats

  • Total investments: 31
  • Round size: Seed $2M–$8.1M; Pre-Seed $322k–$37M; Series A $7.7M–$120M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • SimpL — SimpL is an Italy-based AI sales-intelligence and prospecting platform for B2B sales teams. It researches target companies, identifies relevant buying signals, drafts personalised LinkedIn outreach, manages follow-ups, and helps generate qualified sales meetings.
  • Computis — Computis is an AI company offering software solutions for electronic invoicing, bank reconciliation, tax estimation, and billing services.
  • Helix Robotics — We are building the first commercial soft manipulator
Show all investments...

Opes Italia
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups

Opes Italia Sicaf Euveca is an impact investing Venture Capital fund. Our aim is to invest in companies based in Italy, or with prevalent activity in the country, and that propose solutions that generate a strong social impact and create positive externalities for the community and the territory.

Show more...

Investment focus

  • Industry: E-Commerce, Leisure, Medical
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Italy, Spain

Investor stats

  • Total investments: 13
  • Round size: Seed $440k–$536k; Series A $2.3M–$7.5M; Venture - Series Unknown $2.2M–$4.9M
  • Lead/follow: 77% lead, 23% follow

Portfolio highlights

  • Baluwo — Providing basic essentials has never been this easy. Sending money is not always the solution so we provide easy, fast & convenient ways to send prepaid electricity top-ups, mobile top-ups and basic food items to support your family back home in The Gambia, and very soon in Senegal and Nigeria.
  • Freedome — Freedome is the leading marketplace for outdoor activities in Italy
  • GenomeUp — Rome-based healthtech startup that offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases. GenomeUp's mission is to be a global reference platform to support clinical decision-making for hospitals, laboratories, research centers, and pharmaceuticals to accelerate diagnosis times, improvepatient care and provide knowledge for health prevention, all in less than 24h. Based on these assumptions, the founders decided to evolve the startup and transform it into a Italian Benefit Corporation following the purpose of common benefit by acting responsibly, sustainably and transparently towards stakeholders, people, communities, the territory and the environment.
Show all investments...

P101
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups, 7 in the past 12 months

P101 is an Italian venture capital firm focused on early-stage investments in the digital sector. Agreement to handle personal data I agree I don't agree

Show more...

Investment focus

  • Industry: Software, E-Commerce, Information Technology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Italy, Spain, United States

Investor stats

  • Total investments: 122
  • Round size: Seed $327k–$4.1M; Series A $2.3M–$15M; Venture - Series Unknown $659k–$8.2M
  • Lead/follow: 63% lead, 37% follow
  • Last fund: Likely still investing — raised $265M in 2022

Portfolio highlights

  • Biorsaf — Biorsaf is an IT company that develops mobile apps and web control panels to assist companies to bring efficiency to their operations.
  • Cosmico — We are the platform connecting digital talents with the most ambitious companies, using remote work.We have over 8,000 members and our talents have accelerated dozens of projects alongside big names like Accenture Song, Tangity, Frog, Fjord, Sketchin, EY but also aggressive start-ups like Scalapay, Gimme5, Flowe, Unguess.If you are a digitalprofessional: we offer you a community in which to grow your talent through experiences, networks and cosmic projects.If you are a company: we offer you access to a community of designers, developers and marketers from which to select the talents to accelerate your digital transformation projects. Whether you are a manager or a digital professional, Cosmico is here to help you find your space
  • Agora Labs — Agora Labs is an Italian medical deep-tech enterprise that provides a secure, decentralized infrastructure for real-time health data sharing and privacy-preserving clinical research. The company solves the fundamental privacy and regulatory bottlenecks in healthcare, allowing researchers, life science corporations, and AI developers to collaborate without exposing sensitive patient information.
Show all investments...

Sefea Impact
VC Fund · Padua, Veneto, Italy · 2 investments in Italy Medical startups

Sefea Impact is an asset management company that setting up and managing closed-end alternative investment funds. It aims to generate social impacts through fundamental tools such as tailored finance, technical assistance, and impact measurement.

Show more...

Investment focus

  • Industry: Medical, Health Care, Information Services
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: Italy

Investor stats

  • Total investments: 8
  • Round size: Venture - Series Unknown $777k–$5.9M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Evja — Evja supports growers in optimizing the management and monitoring of irrigation, nutrition and protection of their crops through the use of OPI, the most advanced system for precision agriculture .
  • BionIT Labs — BionIT Labs is an Italian-U.S. company developing prosthetic and robotic technologies built around how humans move, perceive, and interact with the physical world.
  • Planeat.eco — Planeat.eco is the site where you can plan your food shopping in a simple and economical way, starting from the recipes and receiving at home all the ingredients ready for preparation , weighed and divided into compostable containers. They offer their products online.
Show all investments...

Fountain Healthcare Partners
VC Fund · Dublin, Dublin, Ireland · 2 investments in Italy Medical startups

Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Series C
  • Geography: Ireland, United States, France

Investor stats

  • Total investments: 57
  • Round size: Series A $6.3M–$35M; Series B $5.5M–$68M; Series C $4.1M–$110M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $140M in 2019

Portfolio highlights

  • Palyon Medical — Palyon Medical Corporation is a medical device company developing technologies for the treatment of chronic pain, spasticity and other neurological diseases.
  • Neuromod Devices — Neuromod is the global medical device company that developed Lenire, the FDA Approved tinnitus treatment device.
  • Vivasure Medical — Pioneering the Future of Large-Bore Vessel Closure for Arterial and Venous Access. The first and only 100% bio-absorbable, sutureless patch..
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Evotec
VC Fund · Hamburg, Hamburg, Germany · 2 investments in Italy Medical startups

Evotec is a global biotechnology company committed to advancing drug discovery & development together with our partners for medicines that matter.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Seed, Series B
  • Geography: United States, Germany, United Kingdom

Investor stats

  • Total investments: 29
  • Round size: Series A $8.5M–$95M; Series B $21M–$139M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • Aptadir Therapeutics — Reprogramming DNA methylation in disease conditions by RNA therapeutics APTADIR Contact us NEWS Press Release Reprogramming DNA methylation by RNA therapeutics A novel therapeutic approach for untreatable cancers and rare diseases Aberrant methylation by DNA methyltransferase 1 (DNMT1) of certain genes may cause abnormal cell development and lead to disease. Current therapies targeted to inhibit
  • Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
  • Aeovian Pharmaceuticals — Aeovian is a San Francisco based biopharmaceutical company developing novel and highly selective therapeutics modulating mTORC1 pathway.
Show all investments...

Equiter
VC Fund · Turin, Piemonte, Italy · 2 investments in Italy Medical startups

Equiter seleziona, realizza e gestisce investimenti infrastrutturali in capitale di rischio finalizzati allo sviluppo socio-economico del territorio.

Show more...

Investment focus

  • Industry: Medical, Health Care, Information Technology
  • Stage:Seed, Series B
  • Geography: Italy

Investor stats

  • Total investments: 8
  • Round size: Seed $2.2M–$4M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • Busforfun — Shared and Green traveling to experience the world of fun#WeTheFun | Busforfun is a young mobility company traveling in a sustainable, safe and low-cost way across Europe. Busforfun vision is a green and shared mobility to experience the world of fun.#WeTheTech | Busforfun is a combination of high tech-startup, e-commerce-platform andtransportation company, Busforfun is going to establish European largest bus network for events in the short time. Thanks to a powerful search engine, business intelligence, an user-friendly booking system and an extensive route network, Busforfun offers travellers the opportunity to experience the world of fun with lower fares.#WeTheGreen | Our low-emission buses comply with the highest safety and environmental standards, so Busforfun offers a sustainable and convenient alternative to cars. With main partner Treedom, Busforfun plants new trees at any travel worldwide.Live Fun Experience in partnership – our concept for successBusforfun provides customers with great offers at lowest budget, through smart network planning, dynamic price management and an adaptive web engine.Busforfun platform is where the innovation and start-up spirit meet the experience and know-how of traditional bus companies and travel agencies.Incredible success can be attributed to the digitalization of old-fashioned bus travel industry: Busforfun has not suppliers or clients: but partners only!
  • Easy Rain — Leading a new automotive era: our modular ecosystem of virtual sensors and active hardware makes cars and autonomous platforms truly safe in every condition.
  • Faccin Group — Faccin Group leads in manufacturing top tier metal forming & bending machines. Operating as Faccin, Roundo & Boldrini, we offer unparalleled expertise.
Show all investments...

Fondazione Social Venture Giordano dell'Amore
VC Fund · Milan, Lombardia, Italy · 2 investments in Italy Medical startups

FSVGDA aims at the promotion of the impact investing culture, in order to facilitate social innovation.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Venture - Series Unknown, Seed, Pre-Seed
  • Geography: Italy, Mexico

Investor stats

  • Total investments: 31
  • Round size: Seed $205k–$603k; Venture - Series Unknown $29k–$841k
  • Lead/follow: 65% lead, 35% follow

Portfolio highlights

  • C.NEXT — C.NEXT develops innovation projects for businesses and organizations by supporting the economy and territorial regeneration.
  • Vivavoce — Vivavoce supports a team of neurologists, neuropsychologists, and physiotherapists, developing an innovative approach. They offer treatment for stuttering, for which they offer a rehabilitation path based on the MRM-S method. They treat people suffering from stuttering, problems related to voice and language, and the psychological andemotional-behavioral sphere.
  • Way Experience — Way Experience operates in all the entertainment B2C sectors, using augmented and virtual reality technology. They also work in the B2B area by applying their technologies for customized consultancy projects in the following sectors: design, fashion, medical, events, and training.
Show all investments...

Andera Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Italy Medical startups, 12 in the past 12 months

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas: Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Private Equity, Series A
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 196
  • Round size: Series A $10M–$83M; Series B $16M–$83M; Private Equity $112M–$237M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely actively investing — fresh fund, raised $491M in 2026

Portfolio highlights

  • Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
  • Nouscom — Nouscom is a next-generation immunotherapy company developing genetic cancer vaccines and oncolytic viruses..
  • HighLife — HighLife is driven by a mission to deliver innovative treatment options to patients suffering from heart valve diseases.
Show all investments...

Si14
VC Fund · Vicenza, Veneto, Italy · 1 investments in Italy Medical startups

Si14 is a visionary original design and development laboratory for novel technology products that enhance the way we live, work and play. Founded in 2008 and based in Padova, Italy, Si14 turns inspiration into the realization of compelling, cutting-edge products and services that help people connect with their activities and their world, empowerenterprises in realizing greater efficiencies, improve access to vital health screening services for millions worldwide, and much more.

Show more...

Investment focus

  • Industry: Medical, mHealth, Diabetes
  • Stage:Seed
  • Geography: Italy, United States

Investor stats

  • Total investments: 2
  • Round size: Seed $250k–$1.6M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • D-EYE — D-EYE's technology enables healthcare professionals all over the world to quickly screen for problems, photograph them and then distribute them digitally via various secure wireless solutions. They design and manufacture diagnostic instruments.
  • GrowthLever.io — GrowthLever.io is a B2B sales development company that offers full-service outreach providers. The company books meetings for recruiting, marketing, and prof. service companies. It was founded in 2019 and based in Chicago, Illinois.
Show all investments...

RedSeed Ventures
VC Fund · Milano, Lombardia, Italy · 1 investments in Italy Medical startups

RedSeed Ventures is a Venture Capital firm investing in Early Stage Companies and Scaleups, in Europe and more particularly in Italy.

Show more...

Investment focus

  • Industry: Software, Information Technology, Analytics
  • Stage:Seed, Series A, Series B
  • Geography: Italy, Israel, United States

Investor stats

  • Total investments: 16
  • Round size: Seed $669k–$12M; Series A $1.1M–$16M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Leaf Space — Leaf Space offers a global network of ground stations, providing seamless, cost-effective satellite communication with scalable solutions for all mission sizes.
  • Yope — Salo is a discussion platform that erases the borders for people with diverse opinions to let anyone speak up and be heard.
  • CyberRidge — CyberRidge is a deep-tech cybersecurity firm that develops photonic encryption to protect data privacy.
Show all investments...

a|impact
VC Fund · 1 investments in Italy Medical startups

a|impact invests in the prevailing form of equity or quasi-equity, focusing our operations mainly on companies.

Show more...

Investment focus

  • Industry: Health Care, Fashion, Wellness
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: Italy

Investor stats

  • Total investments: 11
  • Round size: Seed $380k–$1.5M; Venture - Series Unknown $418k–$3.3M
  • Lead/follow: 45% lead, 55% follow

Portfolio highlights

  • Id.Eight — D.EIGHT is a brand of eco-friendly sneakers produced from food industry waste and recycled material.
  • AmaliaCare — AmaliaCare is a socially conscious company that gives a new perspective to the world of aged care. AmaliaCare are the premier digital employment agency, specializing in profiling the ideal domestic workers using cutting-edge technology for families seeking dependable assistance for loved ones who are no longer self-sufficient.
  • HARG - Healthy Aging Research Group — HARG researches, develops, and markets dehydrated food preparations with modified textures. The company ensures nutritional principles are the same or even enhanced when compared to those of a typical meal by using only natural ingredients. The R&D activity done in collaboration with the University of Genoa ensures scientific efficacy. HARGseeks to enhance the health and wellbeing of those who struggle with swallowing.
Show all investments...

Metaventures
VC Fund · Leeds, Leeds, United Kingdom · 1 investments in Italy Medical startups

We invest in the Metaverse

Show more...

Investment focus

  • Industry: Gaming, Medical, PC Games
  • Stage:Venture - Series Unknown
  • Geography: Italy, Brazil, United Kingdom

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $174k–$8M
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • 4MDG — 4MDG creates a master data governance software suite that aims to provide management, sanitization, and enrichment of all kinds of information. Their platform focuses on registry cleaning, data governance, data analysis, integrated solutions, and differentiated products, providing businesses with real-time data, automated processes, data integrity,risk reduction, and improved operational efficiency in master data management.
  • Dubit — Choose your path in the Metaverse.
  • CellPly — Cellply offers an automated platform for functional precision medicine. We provide single-cell drug response profiling to guide oncology treatments...
Show all investments...

GM&C Life Sciences Fund
VC Fund · Alderley Edge, Cheshire, United Kingdom · 1 investments in Italy Medical startups

The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United Kingdom, Italy, Germany

Investor stats

  • Total investments: 36
  • Round size: Seed $94k–$1.9M; Series A $1.9M–$4.2M; Venture - Series Unknown $4.3M–$5.8M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
  • Infex Therapeutics — Infex Therapeutics acquire, develop and license drugs to treat pandemic infections.
  • Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Show all investments...

GCM Group
VC Fund · Jakarta, Jakarta Raya, Indonesia · 1 investments in Italy Medical startups

GCM Group is an investment firm.

Show more...

Investment focus

  • Industry: Medical, Genetics, Health Care
  • Stage:Seed
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GenomeUp — Rome-based healthtech startup that offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases. GenomeUp's mission is to be a global reference platform to support clinical decision-making for hospitals, laboratories, research centers, and pharmaceuticals to accelerate diagnosis times, improvepatient care and provide knowledge for health prevention, all in less than 24h. Based on these assumptions, the founders decided to evolve the startup and transform it into a Italian Benefit Corporation following the purpose of common benefit by acting responsibly, sustainably and transparently towards stakeholders, people, communities, the territory and the environment.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Finalca
VC Fund · Bologna, Emilia-Romagna, Italy · 1 investments in Italy Medical startups

Finalca is an Investment Company.

Show more...

Investment focus

  • Industry: Medical, Genetics, Health Care
  • Stage:Seed
  • Geography: Italy

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • GenomeUp — Rome-based healthtech startup that offers an ecosystem of AI-powered solutions for genetic analysis and clinical decision support for diseases. GenomeUp's mission is to be a global reference platform to support clinical decision-making for hospitals, laboratories, research centers, and pharmaceuticals to accelerate diagnosis times, improvepatient care and provide knowledge for health prevention, all in less than 24h. Based on these assumptions, the founders decided to evolve the startup and transform it into a Italian Benefit Corporation following the purpose of common benefit by acting responsibly, sustainably and transparently towards stakeholders, people, communities, the territory and the environment.
Show all investments...

Index Ventures
VC Fund · San Francisco, California, United States · 1 investments in Italy Medical startups

Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.

Show more...

Investment focus

  • Industry: Software, E-Commerce, Internet
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 1090
  • Round size: Seed $1.3M–$12M; Series A $5M–$35M; Series B $10M–$100M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $117M in 2015

Portfolio highlights

  • Ozon — leading e-commerce platform in Russia, first russian marketplace
  • Personio — Personio is the Intelligent HR platform for companies from 10-5,000 employees, powering over 1 million people worldwide. Book your free demo today.
  • Culture Amp — Culture Amp was founded as a result of its members' first hand experiences with the challenge that fast growing organizations face when their core business expands faster than its people can adapt. With years of experience in enterprise organizations, CultureAmp's team has taken more than a walk in your shoes–they've been running inthem. They look to seize an opportunity for a new type of technology- technology that amplifies learning and drives culture, instead of hindering it.
Show all investments...

MPM Capital
VC Fund · Cambridge, Massachusetts, United States · 1 investments in Italy Medical startups

Powering Breakthroughs in Life Sciences

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 225
  • Round size: Series A $9M–$84M; Series B $20M–$125M; Series C $12M–$100M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $850M in 2021

Portfolio highlights

  • Chiasma — We are a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments that help improve the lives of people with rare diseases.
  • Syndax Pharmaceuticals — Syndax Pharmaceuticals is a clinical-stage pharmaceutical company that focuses on an HDAC inhibitor for solid tumors and hematological tumors. It offers therapies to treat solid tumors and lung, breast, and hematological cancer. The company is developing axatilimab, a monoclonal antibody that blocks the colony-stimulating factor 1 (CSF-1) receptor,in development for chronic Graft versus Host Disease, and entinostat, a class I HDAC inhibitor.Syndax Pharmaceuticals pipeline includes and SNDX-5613, a highly selective inhibitor of the Menin–MLL binding interaction, in development for the treatment of patients with MLLr and NPM1 acute leukemias.
  • Portola Pharmaceuticals — As Alexion, AstraZeneca Rare Disease, we are delivering life-changing therapies to people living with rare diseases.
Show all investments...

Rancilio Cube
VC Fund · Milano, Lombardia, Italy · 1 investments in Italy Medical startups

Cube is the investment office founded by Rancilio family

Show more...

Investment focus

  • Industry: E-Commerce, Software, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Italy, Germany

Investor stats

  • Total investments: 66
  • Lead/follow: no public data

Portfolio highlights

  • Convoy — Using technology and automation, the Convoy Platform seamlessly connects carriers with shipments from brokers across the nation.
  • FinCompare - Smarter Business Finance — FinCompare was founded by Stephan Heller and is a fintech startup that helps businesses to find, compare, and close the financing solutions. Via the online platform, companies can access a wide range of financing options. They can independently compare offers from well-known banks, fintechs, and alternative financial services providers in Germanyand close the financing. The company also offers a convenient one-stop destination for all financing questions relating to the company.FinCompare financing solutions including corporate loan, factoring, company leasing/hire purchase, warehouse financing, fine trading/purchase financing, and mezzanine capital. It simplifies the financing process with its digital application process and can thus provide your company financing. The company allows SMEs to receive and compare various offers for loans.FinCompare was founded in October 2016 by Stephan Heller and is headquartered in Berlin, Germany.
  • Finom — Finom is an online payment solution for entrepreneurs that makes it easy to open a business account and securely manage their finances.
Show all investments...

UniCredit
VC Fund · Milan, Lombardia, Italy · 1 investments in Italy Medical startups

UniCredit is a pan-European commercial bank offering unique banking services in Italy, Germany, Central and Eastern Europe.

Show more...

Investment focus

  • Industry: Renewable Energy, Energy, Manufacturing
  • Stage:Debt Financing, Post-IPO Debt, Pre-Seed
  • Geography: Italy, Germany, United States

Investor stats

  • Total investments: 161
  • Round size: Pre-Seed $197k–$197k; Post-IPO Debt $44M–$2.1B; Debt Financing $1.2M–$899M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • Banxware — Banxware provides the technology and the funds for business financing of any kind: fully embedded in your platform or as an affiliate solution - all managed by Banxware
  • DevTwo S.p.A. — DevTwo S.p.A. is a special purpose vehicle belonging to Gruppo Barletta,
  • Gruppo Barletta — Gruppo Barletta specializes in real estate, hospitality, and venture capital for the construction sector.
Show all investments...

European Commission
VC Fund · Brussels, Brussels Hoofdstedelijk Gewest, Belgium · 1 investments in Italy Medical startups, 29 in the past 12 months

The official website of the European Commission, providing access to information about its political priorities, policies and services

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Grant, Seed, Pre-Seed
  • Geography: France, Spain, United Kingdom

Investor stats

  • Total investments: 210
  • Round size: Seed $55k–$10M; Grant $117k–$36M; Pre-Seed $55k–$1.7M
  • Lead/follow: 70% lead, 30% follow
  • Last fund: May invest from a new fund soon — last raise in 2014

Portfolio highlights

  • AFYREN — AFYREN develop innovation in biotechnologies for the valorization of non-food biomass and in respect of the environment.
  • Naturbeads — Naturbeads creates biodegradable, sustainable and cost competitive cellulose microbeads to replace currently used microplastics.
  • USIL Therapeutics — USIL Therapeutics is a biotechnology company focused on radiological preparedness. They develop dual-use medical countermeasures designed to protect populations and mission-critical personnel from ionizing radiation in defense, civilian, and space environments.
Show all investments...

ArchiMed
VC Fund · Lyon, Rhone-Alpes, France · 1 investments in Italy Medical startups

ArchiMed is an independent group with funds provided by the team as well as European and American investors, both institutional and private (including a number of successful healthcare entrepreneurs).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Private Equity, Venture - Series Unknown
  • Geography: Italy, France, Japan

Investor stats

  • Total investments: 9
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $761M in 2021

Portfolio highlights

  • Agatha — Agatha is a provider of strategic software solutions to the health care and life sciences industry. It is dedicated to helping hospitals, biotechnology, pharmaceutical, contract research organizations, and medical device firms optimize the management of their quality and clinical documentation and processes.
  • PlasmidFactory — PlasmidFactory is the leading contract manufacturer and service provider for plasmid DNA and minicircle DNA, custom DNA, In-Stock DNA for AAV and clinical application
  • Ceva Santé Animale — Ceva Sante Animale S.A. engages in the research, development, production, and marketing of pharmaceutical products and vaccines for companion and farm animals. They work with welfare and social programmes around the world to bring this vision to life – anywhere their products and know-how can make a difference and with all kinds of partners. FromUganda, working with small-scale livestock owners and vets to stop sleeping sickness in its tracks, to the UK and USA, where they supply the biggest animal welfare charities with Adaptil® collars to help re-home shelter dogs.
Show all investments...

50 Partners Health
VC Fund · 1 investments in Italy Medical startups

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Medicud — Medicud develops a device for treating wounds with negative pressure dressing.
Show all investments...

Claris Ventures
VC Fund · Torino, Piemonte, Italy · 1 investments in Italy Medical startups

Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Series A, Series B
  • Geography: Italy, United Kingdom

Investor stats

  • Total investments: 17
  • Round size: Seed $2.1M–$11M; Series A $6.1M–$23M; Series B $7.4M–$21M
  • Lead/follow: 59% lead, 41% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Lever Bio — Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.
  • Iama Therapeutics — At IAMA Therapeutics, we are constantly pushing the boundaries of neuroscience drug discovery to develop new medicines and make a difference in the lives of children suffering from brain disorders and their families. Our purpose is to provide a therapeutic solution to children suffering from neurological conditions and provide their families withthe support they need.
  • Haptena Therapeutics — Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, integrating precision oncology and immune engineering. Our research focuses on KRAS-mutant tumors to deliver more effective and durable treatment options.
Show all investments...

Seroba Life Sciences
VC Fund · Dublin, Dublin, Ireland · 1 investments in Italy Medical startups

Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 48
  • Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — raised $111M in 2017

Portfolio highlights

  • Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
  • Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
Show all investments...

Medical VC funding in Italy at a glance

Stats across 181 deals from 192 investors.

192
investors
in Italy Medical startups
181
deals
in Italy Medical startups
$2.1M
median round
in Italy Medical startups
40%
lead investors
lead at least one round
22%
Seed
most common funding stage

Access all 192 VC funds in Italy Medical startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical VC Funds in Italy investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 192 VC funds investing in Italy Medical startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists